Surrozen, Inc. ( SRZN) - Key Metrics
SRZN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.07 | $7.87 | -$0.78 | -$0.79 |
| 2025Q3 | $0.11 | -$8.36 | -$1.05 | -$1.06 |
| 2025Q2 | $0.12 | $4.65 | -$0.72 | -$0.72 |
| 2025Q1 | $0.27 | -$7.43 | -$2.56 | -$2.57 |
SRZN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 0.72 |
| 2025Q3 | ? | -0.39 |
| 2025Q2 | ? | 0.48 |
| 2025Q1 | ? | -0.39 |
SRZN
Price: $24.57
52 week price:
Earnings Per Share: -36.59 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 41336
Market Capitalization: 348.1 million